Managing Unforeseen Project Costs in Clinical Research

Unforeseen costs remain a major barrier to the success of clinical trials. Studies have associated the lack of funding with the failure of clinical trials. Ideally, the process of drug development from discovery to the ready product for consumption is expected to be more than $2.5billion.1,2 This cost excludes any expenses attributed to post-approval clinical […]